Clinical Trials on Graft Failure in New Zealand
Total 1345 results
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedGraft Rejection | Kidney FailureUnited States, Spain, Canada, Switzerland, Austria, Australia, New Zealand
-
Ceryx Medical AustraliaAvaniaNot yet recruitingHeart Failure With Reduced Ejection FractionNew Zealand
-
University of Auckland, New ZealandUnknownEndometriosis | In Vitro Fertilization Implantation FailureNew Zealand
-
The University of QueenslandBaxter Healthcare Corporation; Health Research Council, New Zealand; Australian...CompletedEnd Stage Kidney Disease | Kidney Transplant; Complications | Delayed Graft FunctionAustralia, New Zealand
-
Vital Therapies, Inc.TerminatedAcute Liver Failure | Fulminant Hepatic Failure | Primary Graft Non-Function | Surgically-Induced Liver FailureUnited States
-
Yale UniversityJohns Hopkins University; National Institute of Diabetes and Digestive and...CompletedEnd Stage Renal Disease | Acute Kidney Injury | Graft Failure | Delayed Graft Function | Deceased Donor Kidney TransplantUnited States
-
Hoffmann-La RocheCompletedEnd Stage Renal DiseaseNew Zealand
-
SurModics, Inc.Active, not recruitingHemodialysis Access FailureAustralia, New Zealand
-
Academy of Nutrition and DieteticsCompletedEnd Stage Renal Disease Requiring HemodialysisNew Zealand
-
National University Hospital, SingaporeMonash University; Tan Tock Seng Hospital; University of Otago; Changi General... and other collaboratorsUnknownHeart FailureSingapore, New Zealand, Australia
-
Fisher and Paykel HealthcareTerminatedSleep Disordered Breathing | Congestive Heart FailureNew Zealand
-
Reza Dana, MDUnited States Department of Defense; New York Presbyterian Hospital; Bascom Palmer...CompletedCorneal Neovascularization | Corneal Graft FailureUnited States
-
Alere San DiegoCompletedHeart Failure | Acute Decompensated Heart Failure | Systolic Heart FailureUnited Kingdom, Australia, New Zealand, Sweden, Ireland, Netherlands
-
Columbia UniversityIncyte CorporationTerminatedGraft Vs Host Disease | Steroid Refractory GVHDUnited States
-
University of RochesterWithdrawnActive Chronic Graft Versus Host DiseaseUnited States
-
NYU Langone HealthRecruiting
-
NYU Langone HealthActive, not recruitingGraft-versus-host DiseaseUnited States
-
Stanford UniversityNovartisCompletedLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Peripheral | Bone Marrow Transplant FailureUnited States, Canada
-
Australian and New Zealand Intensive Care Research...Baxter Healthcare CorporationCompletedCritical Illness | Multiple Organ FailureAustralia, New Zealand
-
Memorial Sloan Kettering Cancer CenterRecruitingGraft-Versus-Host Disease | GVHD | UndefinedUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedGraft Versus Host DiseaseUnited States
-
Alleviant Medical, Inc.Active, not recruiting
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedGraft Versus Host DiseaseUnited States
-
Yale UniversityTerminatedGraft Versus Host DiseaseUnited States
-
University of RochesterTerminatedChronic Graft Versus Host DiseaseUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
Unity Health TorontoRoche Pharma AGCompletedDyspnea | Acute Heart Failure | Shortness of BreathCanada, United States, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States, Canada, Australia, Switzerland, Puerto Rico, New Zealand
-
Mesoblast, Inc.No longer availableGraft-Versus-Host DiseaseUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedGraft vs Host Disease | Kidney FailureIndia
-
Northwell HealthWithdrawnAcute GVH DiseaseUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedGraft Versus Host Disease | Hematopoietic Cell Transplantation RecipientUnited States
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
NYU Langone HealthRecruitingGraft Vs Host DiseaseUnited States
-
Columbia UniversityCompletedImplant or Graft; RejectionUnited States
-
SoligenixTerminatedChronic Gastrointestinal Graft vs Host DiseaseUnited States
-
NYU Langone HealthCompleted
-
Regimmune CorporationCompletedGraft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Prevention of aGVHDUnited States
-
Roswell Park Cancer InstituteCompletedGraft Versus Host DiseaseUnited States
-
Genentech, Inc.TerminatedAcute Graft-versus-host DiseaseUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Hackensack Meridian HealthTerminatedGraft Versus Host DiseaseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Genentech, Inc.Completed
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
Cynata Therapeutics LimitedCompletedGraft vs Host DiseaseAustralia, United Kingdom
-
MallinckrodtParexelCompletedChronic Graft Versus Host DiseaseUnited States, France, Germany, United Kingdom, Spain, Italy, Austria, Hungary